Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
27.75
+0.01 (0.04%)
At close: Dec 5, 2025, 4:00 PM EST
27.75
0.00 (0.00%)
After-hours: Dec 5, 2025, 5:01 PM EST
Upstream Bio Market Cap
Upstream Bio has a market cap or net worth of $1.5 billion as of December 5, 2025. Its market cap has increased by 23.04% in one year.
Market Cap
1.50B
Enterprise Value
1.14B
1-Year Change
23.04%
Ranking
Category
Stock Price
$27.75
Market Cap Chart
Since the IPO on October 11, 2024, Upstream Bio's market cap has increased from $393.35M to $1.50B, an increase of 281.23%. That is a compound annual growth rate of 219.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.50B | 70.19% |
| Dec 31, 2024 | 881.13M | 124.01% |
| Oct 11, 2024 | 393.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |